AKT1 and B-cell chronic lymphocytic leukemia: Defective negative regulation is a frequent phenomenon in oncogenic signaling; accordingly, absent or substantially reduced expression of the AKT and ERK negative regulator PHLPP1 is observed in CLL cells, causing an enhanced BCR-mediated AKT, ERK, and GSK3 phosphorylation [61].